¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"chain termination method"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • chain termination method
    »ç½½Á¾·á¹ý, ¿¬¼âÁ¾·á¹ý
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • epilemmal termination
    ½Å°æ¼Ó¸·Á¾¸», ½Å°æ³»¸·Á¾¸»
  • involuntary termination
    °­Á¦Á¾°á
  • closed chain
    ´ÝÈù»ç½½
  • closed-chain compound
    ´ÝÈù»ç½½È­ÇÕ¹°
  • cold chain
    Àú¿ÂÀ¯Áö¸Á
  • chain
    »ç½½, ¿¬¼â
  • chain compound
    »ç½½È­ÇÕ¹°
  • chain cystourethrography
    »ç½½¹æ±¤¿äµµÁ¶¿µ(¼ú)
  • chain fiber
    Çٻ罽¼¶À¯, Çٻ罽±ÙÀ°¼¼Æ÷
  • chain initiation reaction
    ¿¬¼â°³½Ã¹ÝÀÀ
  • chain reaction
    ¿¬¼â¹ÝÀÀ
  • chain saw
    »ç½½Åé
  • chromosome chain
    ¿°»öü»ç½½, ¿°»öü°í¸®
  • food chain
    ¸ÔÀ̻罽
  • gamma chain disease
    °¨¸¶»ç½½º´
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 13 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • termination
    Á¾¸», Á¾·á
  • chain
    »ç½½
  • light chain
    °¡º­¿î»ç½½, °æ¼â
  • respiratory chain
    È£Èí»ç½½
  • side chain
    °ç»ç½½
  • method of experiment
    ½ÇÇè¹æ¹ý
  • method
    ¹æ¹ý, ¹ý
  • analytical method
    ºÐ¼®¹ý
  • blind method
    ´«°¡¸²¹ý
  • projective method
    Åõ»ç¹ý
  • reflection method
    ¹Ý»ç¹ý
  • chain reaction
    ¿¬¼â¹ÝÀÀ
  • polymerase chain reaction
    ÁßÇÕÈ¿¼Ò¿¬¼â¹ÝÀÀ, ÁßÇÕ¿¬¼â¹ÝÀÀ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • chain termination method
    ¿¬¼âÁ¾·á¹ý
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • epilemmal termination
    ½Å°æ¼Ó¸·Á¾¸»
  • involuntary termination
    °­Á¦Á¾°á
  • termination signal
    Á¾·á½ÅÈ£
  • termination
    Á¾¸», Á¾·á
  • chain
    »ç½½
  • chain compound
    »ç½½È­ÇÕ¹°
  • chain cystourethrography
    »ç½½¹æ±¤¿äµµÁ¶¿µ¼ú
  • chain fiber
    (¢¡nuclear chain fiber) Çٻ罽¼¶À¯, Çٻ罽±ÙÀ°¼¼Æ÷
  • chain reaction
    ¿¬¼â¹ÝÀÀ
  • chain saw
    »ç½½Åé
  • chain structure
    »ç½½±¸Á¶, ¿¬¼â±¸Á¶
  • chain initiation reaction
    ¿¬¼â°³½Ã¹ÝÀÀ
  • chromosome chain
    ¿°»öü»ç½½, ¿°»öü°í¸®
  • closed chain
    ´ÝÈù»ç½½
  • cold chain
    Àú¿ÂÀ¯Áö¸Á
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • H chain
    Áß¼â, Á߻罽, H¼â
  • H chain disease
    H-¼âº´, Á߼⺴.
  • H chain disease
    Á߼⺴
  • J chain
    J¼â, J»ç½½
  • J chain
    J »ç½½
  • L chain
    °æ¼â, °æ»ç½½, L¼â
  • Mu heavy chain disease
    Mu Áß¼âÁúȯ
  • PCR(polymerase chain reaction)
    ÁßÇÕ¿¬¼â¹ÝÀÀ
  • alpha chain disease
    ¾ËÆÄ¼âº´(¡­áðÜ»).
  • alpha chain disease
    ¾ËÆÄ¼âÁúȯ
  • alpha-chain disease
    ¾ËÆÄ¼â Áúȯ(¡­áð òðü´)
  • gamma-chain disease
    °¨¸¶¼âº´, Gamma-chain º´
  • heavy chain
    Áß¼â
  • heavy chain
    H¼â(¡­áð), Á߻罽.
  • heavy chain
    Áß¼â, Á߻罽, H¼â
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • chain termination method
    ¿¬¼âÁ¾·á¹ý
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • epilemmal termination
    ½Å°æ³»¸·Á¾¸»(¡­ðûØÇ).
  • involuntary termination
    °­Á¦ Á¾°á
  • termination
    Á¾°á(ðûÌ¿).
  • termination
    Á¾¸»(ðûØÇ).
  • termination signal
    Á¾·á(ðûèç)½ÅÈ£.
  • termination tolerance
    Á¾½Ä°ü¿ë.
  • carbol fuchsin method ; Ziehl-Neelsen method
    Ä«¸£º¼ Ç«½Å¹ý; Áú-´ÏÀϼ¾¹ý ¡ìÇ׻꼺¿°»ö¹ý¡í.
  • alpha (¥á) chain
    ¾ËÆÄ»ç½½, ¾ËÆÄ¼â
  • alpha (¥á) chain disease
    ¾ËÆÄ»ç½½º´, ¾ËÆÄ¼âº´
  • alpha chain disease
    ¾ËÆÄ¼âº´(¡­áðÜ»).
  • alpha chain disease
    ¾ËÆÄ¼âÁúȯ
  • alpha-chain disease
    ¾ËÆÄ¼â Áúȯ(¡­áð òðü´)
  • atomic chain
    ¿øÀÚ¼â(ê«í­áð).
  • beta (¥â) chain
    º£Å¸»ç½½, º£Å¸¼â
  • branched chain amino acid
    ºÐÁö¼â¾Æ¹Ì³ë»ê
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Nuclear chain fiber
    Çٻ罽±ÙÀ°¼¼Æ÷
    [¿¾ ¿ë¾î] ÇÙ¼â
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • brine flotation method
    ½Ä¿°¼öºÎÀ¯¹ý
  • crushing method
    ÆÄ°¢¹ý
  • dilution egg counting method
    Èñ¼®Ãæ¶õ°è»ê¹ý
  • natural emerging method
    ÀÚ¿¬À¯Ãâ¹ý
  • squash method
    ¾ÐÂø¹ý
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • chain termination
    »ç½½Çü¼º(û¡à÷) Á¾·á(ðûÖõ)
  • chain termination codon
    »ç½½Çü¼º(û¡à÷) Á¾·á(ðûÖõ) ÄÚµç
  • chain termination mutation
    »ç½½Çü¼º(û¡à÷) Á¾·á(ðûÖõ) º¯ÀÌ(ܨì¶)
  • termination
    Á¾·á(ðûÖõ)
  • termination codon
    Á¾·á(ðûÖõ)ÄÚµ·
  • termination factor
    Á¾·áÀÎÀÚ (ðûÖõì×í­)
  • chain terminator method
    »ç½½Çü¼º(û¡à÷) Á¾·áÀÚ¹ý(ðûÖõí­Ûö)
  • A chain
    A »ç½½
  • amino acid side chain
    ¾Æ¹Ì³ë»ê(ß«) °ç»ç½½
  • antiparallel chain
    ¿ªÆòÇà(æ½øÁú¼)»ç½½
  • B chain
    B »ç½½
  • beta chain
    º£Å¸ »ç½½
  • branched-chain ketoaciduria
    °ç»ç½½ ŰÅä»ê(ß«)´¢Áõ(Òãñø)
  • carbon chain
    ź¼Ò(÷©áÈ) »ç½½
  • C-chain
    C»ç½½
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • termination
    Á¾¸»
  • chain
    ¿¬¼â, ¼â, °í¸®, »ç½½
  • chain cystography
    »ç½½¹æ±¤Á¶¿µ¼ú
  • acquisition method
    ȹµæ¹æ¹ý
  • bolus-tracking method
    µ¢¾î¸®ÃßÀû¹æ¹ý
  • chemical saturation method
    È­ÇÐÆ÷È­±â¹ý
  • Chopper method
    Chopper ¹ý
  • column diffusion method
    ±âµÕÈ®»ê¹æ¹ý
  • constant field gradient spin echo method
    °íÁ¤°æ»çÀ彺ÇÉ¿¡ÄÚ¹ý
  • fast gradient recalled echo method
    °í¼Ó°æ»çȸº¹¿¡ÄÚ±â¹ý
  • liquid filled stomach method
    ¾×Ã¼Ãæ¸¸À§°Ë»ç¹ý
  • method
    ¹æ¹ý, ¹ý, (¹æ)½Ä
  • octoson scanning method
    ¿ÁÅä¼Õ½ºÄµ¹ý
  • one probe method
    ´ÜÀÏŽÃËÀÚ¹æ½Ä
  • presaturation method
    ÀüÆ÷È­¹ý
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
HI Method Hemagglutination Inhibiting Method; Ç÷±¸ ÀÀÁý ¾ïÁ¦¹ý
ABC absolute basophil count; absolute bone conduction; acalculous biliary colic; acid balance control; a...
PT pain threshold; parathormone; parathyroid; paroxysmal tachycardia; part time; patient; pericardial t...
PTR patellar tendon reflex; patient termination record; patient to return; peripheral total resistance; ...
STOP Study of Hypertension in the Elderly [Sweden] or Swedish Trial in Old Patients with Hypertension; su...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
PTC premature termination codon
TOP termination of pregnancy
PCR polimerase chain reaction method
BEM Boundary Elements Method
CAM Confusion Assessment Method
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • termination
    Á¾¸»
  • thalamic termination
    ½Ã»ó Á¾°á
  • branched chain
    Ãø¼â
  • chain
    ¿¬¼â, ¼â, °í¸®, »ç½½
    ¼±»óÀ¸·Î ´ç°ú ´çÀÌ °áÇÕµÈ ÁýÇÕ¹°. ¿¹ÄÁ´ë È­ÇÕ¹°¿¡ À־ ¿øÀÚ È¤Àº ±âÀÇ ÁýÇÕ, ¶Ç´Â °³°³ ¼¼±ÕÀÌ ¿°ÁÖ ¸ð¾çÀ¸·Î µÈ ¼¼Æ÷ ¸ðÀÓ.
  • chain compound
    »ç½½ È­ÇÕ¹°
  • chain fiber
    ¿¬¼â ¼¶À¯
  • chain initiation reaction
    ¿¬¼â °³½Ã ¹ÝÀÀ
  • chain reflex
    ¿¬¼â ¹Ý»ç
    ÇϳªÀÇ Àڱؿ¡¼­ ´ÙÀ½ÀÇ ÀÚ±ØÀ¸·Î Â÷·Ê·Î ÀüÇØÁ®¼­ ¿ÏÀüÇÑ È°µ¿À¸·Î ³ªÅ¸³ª´Â ÀÏ·ÃÀÇ ¹Ý»ç.
  • chain structure
    ¿¬¼â ±¸Á¶
  • Ehrlich`s side chain theory
    ¿¡¸¦¸®È÷ÀÇ Ãø¼â¼³
    Ç×ü »ý»ê ±âÀü¿¡ ´ëÇÏ¿© Á¦¾ÈµÈ °¡¼³ÀÇ Çϳª. ¸ðµç ü ¼¼Æ÷ Ç¥¸é¿¡´Â Ãø¼â¶ó°í ÇÏ´Â ¼ö¿ëü°¡ ÀÖ°í, À̰Ϳ¡ ´ëÀÀÇÏ´Â Ç׿øÀÌ °áÇÕÇϸé Ȱ¼ºÈ­ µÇ°í, Ãø¼â°¡ °úÀ× »ý»êµÇ¾î Ç×ü·Î¼­ Ç÷·ù ¼Ó¿¡ ¹æÃâµÈ´Ù°í ÇÏ´Â »ý°¢. Ç×ü »ý»êÀÇ ¼±Åü³ÀÇ ÃÖÃÊÀÇ °ÍÀÌ´Ù.
  • H chain
    Áß¼â, Á߻罽, H¼â
  • heavy chain
    H »ç½½, H ¼â, Áß¼â
    1. ¸é¿ª ±Û·ÎºÒ¸°ÀÇ ÇÑ ºÎºÐ. 2. ¸é¿ª ±Û·ÎºÒ¸°À» ±¸¼ºÇϰí ÀÖ´Â µÎ °³ÀÇ ºÐÀÚ¼âÀÇ ºÐÀÚ·®ÀÌ Å« Æú¸®ÆéŸÀ̵带 ¸»ÇÑ´Ù.
  • heavy chain disease
    H ¼âº´, Á߼⺴
    ´ÜŬ·Ð¼ºÀÇ °¨¸¶ ±Û·ÎºÒ¸° ÀÌ»óÀ¸·Î¼­, Ç׿ø¼º °áÁ¤ ÀÎÀÚ°¡ °á¿©µÈ ¸é¿ª ±Û·ÎºÒ¸°ÀÌ »ý»êµÈ´Ù.
  • J chain
    J¼â, J »ç½½, ¿¬°á »ç½½
  • joining chain
    ¿¬°á »ç½½, ¿¬°á ¼â
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
peptide chain termination The process whereby the last amino acid is added to a polypeptide. This termination is signaled by one of three termination triplets in the mRNA, immediately following the last amino acid codon.
(12 Dec 1998)
chain, orthodontic chain <dentistry> A stretchable plastic chain used to hold archwires into brackets and to moke teeth.
(08 Jan 1998)
peptide termination factors Proteins that are exclusively involved in the termination reactions of protein synthesis on the ribosome.
(12 Dec 1998)
termination <molecular biology> Stop of mRNA synthesis (i.e., transcription) at the terminator site
Top of protein synthesis (i.e., translation) at the stop codon.
(09 Oct 1997)
termination codon <molecular biology> The three codons, UAA known as ochre, UAG as amber and UGA as opal, that do not code for an amino acid but act as signals for the termination of protein synthesis.
They are not represented by any tRNA and termination is catalysed by protein release factors. There are two release factors in E. Coli, RF1 recognises UAA and UAG, RF2 recognises UAA and UGA. Eukaryotes have a single GTP requiring factor, eRF.
See: ochre suppressor, amber suppressor.
(13 Jan 1998)
termination factor <molecular biology> Any of several proteins in the cytosol that cut a completed polypeptide loose from a ribosome.
(13 Jan 1998)
termination region <molecular biology> A DNA sequence that signals the end of transcription.
(13 Jan 1998)
termination sequence <molecular biology> The three codons, UAA known as ochre, UAG as amber and UGA as opal, that do not code for an amino acid but act as signals for the termination of protein synthesis.
They are not represented by any tRNA and termination is catalysed by protein release factors. There are two release factors in E. Coli, RF1 recognises UAA and UAG, RF2 recognises UAA and UGA. Eukaryotes have a single GTP requiring factor, eRF.
See: ochre suppressor, amber suppressor.
(13 Jan 1998)
A chain A polypeptide component of insulin containing 21 amino acyl residues, beginning with a glycyl residue (NH2-terminus); insulin is formed by the linkage of an A chain to a B chain by two disulfide bonds; the amino-acid composition of the A chain is a function of species.
Synonym: glycyl chain.
In general, one of the polypeptides in a multiprotein complex.
(05 Mar 2000)
alpha chain disease A vague or indefinite term; could be used for alpha-heavy-chain disease (a lymphoplasma cell proliferative disease usually seen in Mediterranean men, characterised by intestinal involvement with steatorrhoea, often progressive with fatal outcome) or a thalassaemia (a genetic abnormality in the alpha globin chain of haemoglobin).
(05 Mar 2000)
amino acids, branched-chain Amino acids which have a branched carbon chain.
(12 Dec 1998)
B chain A polypeptide component of insulin containing 30 amino acyl residues, beginning with a phenylalanyl residue (NH2-terminus); insulin is formed by the linkage of a B chain to an A chain by two disulfide bonds; the amino-acid composition of the B chain is a function of species.
Synonym: phenylalanyl chain.
(05 Mar 2000)
behaviour chain Related behaviours in a series in which each response serves as a stimulus for the next response.
(05 Mar 2000)
branched chain acyl-CoA oxidase <enzyme> Enzyme from human liver peroxisomes acts on both 2-methyl branched fatty acyl- and bile acid-CoA intermediates, unlike rat liver peroxisomes which have separate enzymes for branched chain fatty acids (pristanoyl-CoA) and bile acid-CoA; involved in beta-oxidation of fatty acids and bil
Registry number: EC 1.3.3.-
Synonym: 2-methyl-branched chain acyl-CoA oxidase, hbrcacox
(26 Jun 1999)
branched-chain fatty-acid-kinase <enzyme> From anaerobic spirochete ma-2
Registry number: EC 2.7.2.14
Synonym: isovalerate kinase, 2-methylbutyrate kinase, isobutyrate kinase
(26 Jun 1999)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • termination
    °á¸»
  • termination
    Á¾°á;¸¸±â;¸»´Ü;ÇѰè
  • chief method
    ÁÖ¿ä ¼ö´Ü
  • method
    ¹æ¹ý,¼ø¼­,¹æ½Ä
  • Ericsson method
    ¿¡¸¯½¼ ¹ý(Àΰø ¼öÁ¤¹ýÀÇ Çϳª)
  • Grams method
    ±×·¥ ¿°»ö¹ý(¿°»öÇÏ¿© ¼¼±ÕÀ» ¾ç¼º°ú À½¼ºÀ¸·Î ºÐ·ù ½Äº°ÇÏ´Â ¹ý ç¼
  • Monte Carlo method
    ¸óÅ×Ä«¸¦·Î¹ý(º¹ÀâÇÑ ¹°¸® Çö»óÀ» ¼öÇÐÀûÀ¸·Î Ç®±â À§ÇÏ¿© ³­ ¼ö Ç¥·ê »ç¿ëÇÏ´Â ¹æ¹ý)
  • Montessori method(system)
    (ÀÌÅ»¸®¾ÆÀÇ ¿©¼º ±³À°°¡ À̸§¿¡¼­) ¸óÅ×¼Ò¸®½Ä ±³À°¹ý(¾Æµ¿ÀÇ ÀÚÁÖ¼ºÀÇ ½ÅÀåÀ» Áß½ÃÇÑ ±³À°¹ý) m`
  • case method
    »ç·Ê ¿¬±¸¹ý;=CASE SYSTEM
  • critical path analysis (method)
    Å©¸®Æ¼Äà ÆÐ½º ºÐ¼®¹ý(ÇÁ·ÎÁ§Æ®ÀÇ °èȹ.°ü¸®¸¦ °úÇÐÀûÀ¸·Î ÇÏ´Â ¹æ¹ý)
  • direct method
    (¿Ü±¹¾îÀÇ)Á÷Á¢ ±³¼ö¹ý(¿Ü±¹¾î¸¸À¸·Î °¡¸£Ä¡¸ç ¹®¹ý ±³À°µµ ÇÏÁö ¾ÊÀ½)
  • discovery method
    ¹ß°ß ÇнÀ¹ý(Çлý¿¡°Ô ÀÚÁÖÀûÀÎ Áö½Ä ½Àµæ,¹®Á¦ ÇØ°áÀ» ½ÃŰ´Â ±³À°¹ý) er
  • field method
    ¾ß¿Ü ¿¬±¸¹ý !
  • graduated length method
    Á¡Â÷Àû ±æÀÌ º¯°æ¹ý(±â¼úÀÇ Çâ»ó¿¡ µû¶ó ½ºÅ°¸¦ ±ä °ÍÀ¸·Î Á¡Â÷ ¹Ù²Ù¾î °¡´Â ½ºÅ° Áöµµ¹ý)
  • method
    ¹æ¹ý;¹æ½Ä;(±ÔÄ¢¹Ù¸¥)¼ø¼­;Áú¼­
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á